Discover Synthesis — our technical newsletter spotlighting the latest innovations and expert insights in pharmaceutical development and manufacturing. Each issue delivers concise updates on breakthrough science, process advancements and real-world solutions from industry peers.
Stay informed and inspired. Sign up now to receive the first issue of Synthesis and join a community advancing pharma innovation.
Hero Image Section
Perspectives from a different brand of experts
Thank you for subscribing!
Our first issue is headed your way.
Section1
The Science of Drug Development: A Roundtable Event in Cambridge
Boston Marriott Cambridge
50 Broadway, Cambridge Wednesday, April 12, 2023
10 a.m. - 1 p.m.
Join us on Wednesday, April 12th in Cambridge for, “The Science of Drug Development: A Roundtable Event.” The event will be hosted at the Cambridge Marriott from 10 a.m. to 1 p.m and includes complimentary valet parking.
To RSVP for this event, please complete our registration form. We look forward to meeting you in Cambridge!
Authors:
Dan Bowles, PhD
Senior Director, Chemical Development, Cambrex
Mike Johnson
Senior Director, Quality, Cambrex
Brian Swierenga
VP, Operations and Site Director, Cambrex
Panelists
Agenda
4:15 PM Gates Open - Enter the event via private entrance at 14 Lansdowne Street, across from the House of Blues. You and your colleague will not need a ticket to enter, as we will be providing entry via guest list. |
4:30 PM Tour of Fenway Park - Includes an on-field experience during batting practice (weather permitting). |
4:30 PM Dinner Buffet and Drink Cart Open - Dinner includes a classic selection of ballpark foods, including vegan, vegetarian and gluten-free options. |
6:10 PM Game Start |
7:10 PM Dinner Buffet Closes - Peanuts, Cracker Jacks and popcorn available until the 7th inning. |
9:10 PM Drink Cart Closes (or 7th inning, whichever occurs first). |
Agenda Section
Agenda
4:15 PM |
4:30 PM |
4:30 PM |
6:10 PM |
7:10 PM |
9:10 PM |
Button Section
Speaker Section
Panelists
Two Column1
News
Cambrex Names Thomas Loewald As Chief Executive Officer
19.06.2020
Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Tom Loewald has been named Chief Executive Officer and a member of the company’s Board of Directors, effective September 7th.
Two Column2
Cambrex Names Thomas Loewald As Chief Executive Officer
19.06.2020
Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Tom Loewald has been named Chief Executive Officer and a member of the company’s Board of Directors, effective September 7th.
Resources
Related Resources
Whitepaper
Making Medicines: Speeding the Path from Idea to Patient
Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced...
Market Trends Regulatory
Whitepaper
Route development: designing synthesis for GMP production
Partner with a CDMO who can deliver right-sized solutions for your small-volume prog ram at each stage and grow with you from early development through commercialization.
Market Trends
Whitepaper
Route development: designing synthesis for GMP production
Enhanced by our uncompromising commitment to current good manufacturing practice (cGMP) standards and a proven track record in compliance, we are an expert partner you can trust.
Regulatory